Haisco Pharmaceutical Group Co., Ltd. Stock: price and insider trades · China
海思科
Haisco Pharmaceutical Group Co., Ltd.: what insiders have been doing
Haisco Pharmaceutical Group Co., Ltd. is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). No insider at Haisco Pharmaceutical Group Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 29 December 2023.
The full history, which starts in 2023, counts no purchases against 5 sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Analyst consensus: bullish or bearish?
Analysts rate Haisco Pharmaceutical Group Co., Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: CN¥88.45.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,921,000 shares100.0% of flowA股XSHESZSE:173000007201516740
- 1,140,000 shares10.5% of flowA股XSHESZSE:173000006588598720
- 500,000 shares4.6% of flowA股XSHESZSE:173000006579405630
- 8,515,000 shares81.1% of flowA股XSHESZSE:173000006546687780
- 400,000 shares3.8% of flowA股XSHESZSE:173000006536417250
5 of 5 declarations
About Haisco Pharmaceutical Group Co., Ltd.
海思科 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and commercialization of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
